Angioedema in heart failure: Occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy

Congestive Heart Failure

Volumn 8, Issue 6, 2002, Pages

  Sica, Domenic A ^a   Black, Henry R ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; ARGININE CARBOXYPEPTIDASE; CANDESARTAN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FRESH FROZEN PLASMA; LOSARTAN; OMAPATRILAT; SPIRAPRIL; VALSARTAN;

AIRWAY; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONSERVATIVE TREATMENT; DRUG SAFETY; DRUG TOLERANCE; HUMAN; INCIDENCE; INTUBATION; KALLIKREIN KININ SYSTEM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

EID: 0036859387     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2002.01529.x     Document Type: Article

References (65)

1. Herkner H, Temmel AF, Mullner M, et al. Different patterns of angioedema in patients with and without angiotensin-converting enzyme inhibitor therapy. Wien Klin Wochenschr. 2001;113:167-171.
2. Binder M, Kittler H. Angioedema and antihypertensive therapy. Wien Klin Wochenschr. 2001;113:154-156.
3. Agah R, Bandi V, Guntupalli KK. Angioedema: The role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med. 1997;23:793-796.
4. Lapostolle F, Borron SW, Bekka R, et al. Lingual angioedema after perindopril use. Am J Cardiol. 1998;81:523.
5. Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci. 2001;46:1239-1243.
6. Kuo DC, Bairsh RA. Isolated uvular angioedema associated with ACE inhibitor use. J Emerg Med. 1995;13:327-330.
7. Oudit G, Girgrah N, Allard J. ACE inhibitor-induced angioedema of the intestine: Case report, incidence, pathophysiology, diagnosis and management. Can J Gastroenterol. 2001;15:827-832.
8. Byrne TJ, Douglas DD, Landis ME, et al. Isolated visceral angioedema: An underdiagnosed complication of ACE inhibitors? Mayo Clin Proc. 2000;75:1201-1204.
9. Schmidt TD, McGrath KM. Angiotensin-converting enzyme inhibitor angioedema of the intestine: A case report and review of the literature. Am J Med Sci. 2002;324:106-108.
10. Wood SM, Mann RD, Rawlins MD. Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors. Br Med J Clin Res. 1987;294:91-92.
11. Vleeming W, van Amsterdam JG, Stricker BH, et al. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf. 1998;18:171-188.
12. Ulmer JL, Garvey MJ. Fatal angioedema associated with lisinopril. Ann Pharmacother. 1992;26:1245-1246.
13. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA. 1988;260:967-970.
14. Blomberg PJ, Surks HK, Long A, et al. Transient myocardial dysfunction associated with angiotensin-converting enzyme inhibitor-induced angioedema: Recognition by serial echocardiographic studies. J Am Soc Echocardiogr. 1999;12:1107-1109.
15. Jett GK. Captopril-induced angioedema: First report. Ann Emerg Med. 1984;13:489-490.
16. th, 2002 http://www.theheart.org. Accessed, September 5th, 2002.
17. Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacother. 2000;34:526-528.
18. van Rijnsoever EW, Kwee-Zuiderwijk WJ, Feenstra J. Angioneurotic edema attributed to the use of losartan. Arch Intern Med. 1998;158:2063-2065.
19. Sharma PK, Yium JJ. Angioedema associated with angiotensin II receptor antagonist losartan. South Med J 1997;90:552-553.
20. Rupprecht R, Vente C, Grafe A, et al. Angioedema due to losartan. Allergy. 1999;54:81-82.
21. Rivera JO. Losartan-induced angioedema. Ann Pharmacother. 1999;33:933-935.
22. Cha YJ, Pearson VE. Angioedema due to losartan. Ann Pharmacother. 1999;33:936-938.
23. Chiu AG, Newkirk KA, Davidson BJ, et al. Angiotensin-converting enzyme inhibitor-induced angioedema: A multicenter review and an algorithm for airway management. Ann Otol Rhinol Laryngol. 2001;110:834-840.
24. Frye CB, Pettigrew TJ. Angioedema and photosensitive rash induced by valsartan. Pharmacotherapy. 1998;18:866-868.
25. Fuchs SA, Koopmans RP, Guchellaar HJ. Are angiotensin-II receptor antagonists safe in patients with previous angiotensin-converting enzyme inhibitor-induced angioedema [letter]? Hypertension. 2001;37:E1.
26. Acker CG, Greenberg A. Angioedema induced by the angiotensin II blocker losartan [letter]. N Engl J Med 1995;333:1572.
27. Boxer M. Accupril and Cozaar-induced angioedema in the same patient [letter]. J Allergy Clin Immunol. 1996;98:471.
28. Shionoiri H, Takasaki I, Hirawa N, et al. A case report of angioedema during long-term (66 months) angiotensin converting enzyme inhibition therapy with enalapril. Jon Circ J. 1996;60:166-170.
29. Dyer PD. Late-onset angioedema after interruption of angiotensin-converting enzyme inhibitor therapy. J Allergy Clin Immunol. 1994;93:947-948.
30. Kostis JB, Wilson AC. Incidence of angioedema in SOLVD [abstract]. J Am Coll Cardiol. 2002;39(supp 1):166A.
31. Packer M, Califf RM, Konstam M, et al. Comparison of omapatrilat and enalapril in patients with chronic heart failure. Circulation. 2002;106:920-926.
32. Rubinstein I, Muns G, Zucker IH. Plasma exudation in conscious dogs with experimental heart failure. Basic Res Cardiol. 1994;89:487-498.
33. Cugno M, Agostoni P, Brunner HR. Plasma bradykinin levels in human chronic congestive heart failure. Clin Sci. 2000;99:461-466.
34. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Safe. 2001;24:599-606.
35. Gabb GM, Ryan P, Wing LM, et al. Epidemiological study of angioedema and ACE inhibitors. Aust NZ J Med. 1996;26:777-782.
36. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA. 1997;278:232-233.
37. Weiner JM. Failure to recognize the association of life-threatening angio-edema and angiotensin converting enzyme inhibitor therapy. Aust NZ J Med. 1995;25:241-242.
38. Finley CJ, Silverman MA, Nunez AE. Angiotensin-converting enzyme inhibitor-induced angioedema: Still unrecognized. Am J Emerg Med. 1992;10:550-552.
39. Gregory KW, Davis RC. Images in clinical medicine. Angioedema of the intestine. N Engl J Med. 1996;334:1641.
40. Orfan N, Patterson R, Dykewicz MS. Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema. JAMA. 1990;264:1287-1289.
41. Megerain CA, Arnold JE, Berger M. Angioedema: 5 years' experience, with a review of the disorder's presentation and treatment. Laryngoscope. 1992;102:256-260.
42. Brown NJ, Ray WA, Snowden M, et al. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996;60:8-13.
43. Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors: Increased risk in patients of African origin. Br J Clin Pharmacol. 1999;48:861-865.
44. Gainer JV, Nadeau JH, Ryder D, et al. Increased sensitivity to bradykinin among African-Americans. J Allergy Clin Immunol. 1996;98:283-287.
45. Abbosh J, Anderson JA, Levine AB, et al. Angiotensin converting enzyme inhibitor-induced angioedema prevalent in transplant patients. Ann Allergy Asthma Immunol. 1999;82:473-476.
46. Agostoni A, Cicardi M, Cugno M, et al. Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology. 1999;44:21-25.
47. Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol. 2002;109:195-209.
48. Nussberger J, Cugno M, Amstutz C, et al. Plasma bradykinin in angio-edema. Lancet. 1998;351:1693-1697.
49. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med. 2002;347:621-622.
50. Sigler C, Annis K, Cooper K, et al. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor. Arch Dermatol. 1997;133:972-975.
51. Adam A, Cugno M, Molinaro G, et al. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet. 2002;359:2088-2089.
52. Lefebvre J, Murphey LJ, Hartert TV, et al. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension. 2002;39:460-464.
53. Pracy JP, McGlashan JA, Walsh RM, et al. Angioedema secondary to angiotensin-converting enzyme inhibitors. J Laryngol Otol. 1994;108:696-698.
54. Karim MY, Masood A. Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema. J Allergy Clin Immunol. 2002;109:370-371.
55. Sabroe RA, Glendinning AK, Sabroe I, et al. An audit of the use of self-administered adrenaline syringes in patients with angio-oedema. Br J Dermatol. 2002;146:615-620.
56. Tisch M, Lampl L, Groh A, et al. Angioneurotic edemas of the upper aerodigestive tract after ACE-inhibitor treatment. Eur Arch Oto-Rhino-Laryngol. [serial online]. DOI 10.1007/S00405-002-0481-Y.
57. Chiu AG, Krowiak EJ, Deeb ZE. Angioedema associated with angiotensin II receptor antagonists: Challenging our knowledge of angioedema and its etiology. Laryngoscope. 2001;111:1729-1731.
58. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet. 2002;359:995-1003.
59. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667-1675.
60. Granger CB, Ertl G, Kuch J, et al. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J. 2000;139:609-617.
61. Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582-1587.
62. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA. 2002;287:628-640.
63. de Denus S, Spinler SA. Treatment of congestive heart failure. JAMA. 2002;287:2209-2210.
64. Howes LG, Tran D. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf. 2002;25:73-76.
65. Vidt DG. Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor? Cleve Clin J Med. 2001;68:189-190.